Van Lanschot Kempen Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35M | Sell |
44,903
-5,841
| -12% | -$4.55M | 0.33% | 53 |
|
|
2025
Q1 | $41.9M | Buy |
50,744
+21,940
| +76% | +$18.1M | 0.44% | 51 |
|
|
2024
Q4 | $22.2M | Buy |
28,804
+7,255
| +34% | +$5.6M | 0.22% | 103 |
|
|
2024
Q3 | $19.1M | Buy |
21,549
+461
| +2% | +$408K | 0.19% | 116 |
|
|
2024
Q2 | $19.1M | Buy |
+21,088
| New | +$19.1M | 0.21% | 105 |
|
|
2023
Q2 | – | Sell |
-150
| Closed | -$51.5K | – | 217 |
|
|
2023
Q1 | $51.5K | Hold |
150
| – | – | ﹤0.01% | 197 |
|
|
2022
Q4 | $54.9K | Sell |
150
-48
| -24% | -$17.6K | ﹤0.01% | 192 |
|
|
2022
Q3 | $64K | Buy |
198
+11
| +6% | +$3.56K | ﹤0.01% | 191 |
|
|
2022
Q2 | $61K | Sell |
187
-32
| -15% | -$10.4K | ﹤0.01% | 191 |
|
|
2022
Q1 | $63K | Sell |
219
-128
| -37% | -$36.8K | ﹤0.01% | 186 |
|
|
2021
Q4 | $96K | Sell |
347
-46
| -12% | -$12.7K | ﹤0.01% | 174 |
|
|
2021
Q3 | $91K | Buy |
393
+17
| +5% | +$3.94K | ﹤0.01% | 187 |
|
|
2021
Q2 | $86K | Buy |
+376
| New | +$86K | ﹤0.01% | 183 |
|
|
2014
Q2 | – | Sell |
-8,800
| Closed | -$517K | – | 99 |
|
|
2014
Q1 | $517K | Hold |
8,800
| – | – | 0.05% | 89 |
|
|
2013
Q4 | $448K | Buy |
+8,800
| New | +$448K | 0.04% | 91 |
|